|Articles|May 15, 2017
- Pharmaceutical Technology-05-15-2017
- Volume 2017 eBook
- Issue 1
Parallel Processing
Author(s)Agnes Shanley
Samsung BioLogics’ aggressive growth strategy begs the question: Are there lessons that US and European pharma might still learn from the electronics industry?
Advertisement
A look at how engineering-led companies from outside pharma are transforming biopharmaceutical contract services, and an interview with Samsung BioLogics’ vice president and head of business development, James Park, on the company’s history, culture, and plans.
Download
.
Articles in this issue
over 8 years ago
Clean, Disinfect, and Validateover 8 years ago
Kill the Bioburden, Not the Biological Indicatorover 8 years ago
Ensuring the Biological Integrity of Raw Materialsover 8 years ago
Getting Biopharmaceutical Tech Transfer Right the First Timeover 8 years ago
Case Study: Retrofitting Two New High-Purity Water Systemsover 8 years ago
Single-Use Bioreactors Have Reached the Big Timeover 8 years ago
Cost Considerations Drive Lean Technology in BiomanufacturingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
2
AI and Human Collaboration Essential for Bio/pharma Innovation
3
Sustainability and Stability in Excipients
4
Centralizing AI Strategy, Ensuring Process Integrity, and Balancing Quick Wins with Long-Term Drug Design in Bio/pharma
5
